Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance

Feb. 8, 2018 12:30 UTC EDEN PRAIRIE, Minn.–(BUSINESS WIRE)– SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2018 first quarter, ended December 31, 2017, and updated financial outlook for fiscal 2018. “We are making steady […]

Cardiovascular Systems Names a New CFO, Effective Immediately

Feb. 7, 2018 21:06 UTC Cardiovascular Systems, Inc. Appoints Jeff Points as Chief Financial Officer Larry Betterley to Retire in August 2018 ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that Jeff Points was named Chief Financial Officer (CFO), effective immediately. As part of a planned succession, Points […]

REVA Announces Appointment of Stephen Oesterle, MD to Board of Directors

SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) — REVA Medical (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announces the appointment of Stephen Oesterle, MD to its Board of Directors, effective immediately. Dr. Oesterle brings significant clinical, medical device and board expertise to REVA. He is […]

The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%

LONDON, Jan. 31, 2018 /PRNewswire/ — The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%. The major factors driving the growth of this market are the high burden of abdominal aneurysms, increasing geriatric population, and increasing prevalence of smoking & other […]

Medtronic Closes $28M Purchase of QT Vascular’s Chocolate PTA Balloon Catheter

Medtronic Completes the Purchase of QT Vascular’s Chocolate PTA Balloon Catheter Highlights: – Medtronic completes the purchase of the Company’s non-drug coated Chocolate® PTA balloon catheter – The completion of this purchase validates the value of this internally developed specialty PTA to improve outcomes in patients with peripheral artery disease PLEASANTON, Calif., […]

Endologix Appoints Greg Morrow as Chief Marketing Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that it has appointed Greg Morrow as the Company’s Chief Marketing Officer, effective immediately. Mr. Morrow brings to Endologix a wealth of executive marketing experience in medical devices. Most recently, he led the Coronary […]

Vascular Insights® Announces New Chief Executive Officer

QUINCY, Mass., Jan. 25, 2018 /PRNewswire/ — Vascular Insights® announced that its Board of Directors has appointed James P. Ott as President and CEO. Jim brings to the position greater than 20 years of experience as President for companies in the manufacturing and medical device industries. He has held numerous leadership positions that have focused on […]

Endologix, Inc. to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on February 21, 2018

IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the fourth quarter and fiscal year 2017 after the market close on Wednesday, February 21, 2018. The Company’s management will host a conference call at 4:30 […]